Welcome to the CMR International Institute for Regulatory Science
|
About the Institute The CMR International Institute for Regulatory Science (the Institute) is the vehicle through which the international pharmaceutical industry, regulatory authorities and academia meet, debate and develop regulatory policy. The objectives of the Institute are to facilitate dialogue and productive discussions in order to promote better understanding of the science that will form the basis for regulatory policy; to play an active and pro-active role in the evolution and harmonisation of international regulatory requirements and approval procedures; to act as a catalyst for the adoption of best practice in global regulatory affairs; to provide a neutral, professional forum through which peers can meet and share best practice; and to pursue research that supports the Institute's mission. The work programme for the Institute for 2009 is set out in the Agenda. |
||
Next Workshops 29–30 September 2009: Review and Reimbursement— A special case for better cooperation A collaborative workshop between CMR International Institute for Regulatory Science and the Office of Health Economics in the UK 23–24 November 2009: Emerging Markets — Ethnic Factors in Drug Development |
Research Activities Benchmarking the Regulatory Review Process more... Scorecards: Building Quality into Regulatory Submission and Review more...
Benefit-Risk Assessment of Medicines more... Emerging Markets more... |
For Members Restricted-access reports and research available to Institute members |
